Literature DB >> 16340786

Persistent, asymptomatic, microscopic hematuria in prospective kidney donors.

Rahul Koushik1, Catherine Garvey, J Carlos Manivel, Arthur J Matas, Bertram L Kasiske.   

Abstract

BACKGROUND: Asymptomatic, microscopic hematuria is seen in 8-21% of the general population, has a good prognosis, and is generally not an indication for kidney biopsy. But whether it should preclude kidney donation is unclear.
METHODS: Of 512 consecutive prospective donors, 14 (2.7%) continued to have asymptomatic, microscopic hematuria over 1 month. If the medical history, physical examination, and computerized tomographic angiography were unremarkable, and if they still wished to donate, a kidney biopsy was performed.
RESULTS: In two prospective donors, hematuria resolved after treatment for urinary tract infection; two others declined donation and were referred to their primary care provider. Kidney biopsy in the remaining 10 showed: two normal; four thin basement membrane nephropathy (TBMN); one nonhomogeneous basement membrane abnormalities; one IgA nephropathy, 5 of 16 glomeruli globally sclerotic; one in a patient with a family history of Schimke's Syndrome, 7 of 30 glomeruli globally sclerotic; and one TBMN and early hypertensive changes without systemic hypertension. Only 4 of the 10 who underwent kidney biopsy donated (two normal, two TBMN).
CONCLUSIONS: Kidney abnormalities are common in young, otherwise healthy, prospective kidney donor candidates with persistent, asymptomatic, microscopic hematuria. A kidney biopsy is often abnormal and aids in the decision-making process.

Entities:  

Mesh:

Year:  2005        PMID: 16340786     DOI: 10.1097/01.tp.0000181098.56617.b2

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice.

Authors:  Amit X Garg; Andrew S Levey; Bertram L Kasiske; Michael Cheung; Krista L Lentine
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 8.237

Review 2.  Renal and cardiac assessment of living kidney donor candidates.

Authors:  Ngan N Lam; Krista L Lentine; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2017-04-03       Impact factor: 28.314

3.  Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.

Authors:  A D Muzaale; A B Massie; S Anjum; C Liao; A X Garg; K L Lentine; D L Segev
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

4.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

5.  Guidelines for Genetic Testing and Management of Alport Syndrome.

Authors:  Judy Savige; Beata S Lipska-Zietkiewicz; Elizabeth Watson; Jens Michael Hertz; Constantinos Deltas; Francesca Mari; Pascale Hilbert; Pavlina Plevova; Peter Byers; Agne Cerkauskaite; Martin Gregory; Rimante Cerkauskiene; Danica Galesic Ljubanovic; Francesca Becherucci; Carmela Errichiello; Laura Massella; Valeria Aiello; Rachel Lennon; Louise Hopkinson; Ania Koziell; Adrian Lungu; Hansjorg Martin Rothe; Julia Hoefele; Miriam Zacchia; Tamara Nikuseva Martic; Asheeta Gupta; Albertien van Eerde; Susie Gear; Samuela Landini; Viviana Palazzo; Laith Al-Rabadi; Kathleen Claes; Anniek Corveleyn; Evelien Van Hoof; Micheel van Geel; Maggie Williams; Emma Ashton; Hendica Belge; Elisabet Ars; Agnieszka Bierzynska; Concetta Gangemi; Alessandra Renieri; Helen Storey; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-20       Impact factor: 8.237

Review 6.  Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.

Authors:  Yasar Caliskan; Krista L Lentine
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.651

7.  Persistent asymptomatic isolated hematuria in children: clinical and histopathological features and prognosis.

Authors:  Chun-Yue Feng; Yong-Hui Xia; Wen-Jin Wang; Jin Xia; Hai-Dong Fu; Xia Wang; Hui-Jun Shen; Gu-Ling Qian; Ai-Min Liu; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2013-05-16       Impact factor: 2.764

8.  IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation.

Authors:  John Irvine; Nicholas Cross; Kelvin Lynn; Richard Robson; Martin Searle; John Morton; Sarah Armstrong; Justin Roake
Journal:  Clin Kidney J       Date:  2012-03-26

Review 9.  Controversies related to living kidney donors.

Authors:  Ahmed I Kamal; Ahmed M Harraz; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2011-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.